Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain
CompletedNot applicableNCT02795026
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic Pelvic Pain (CPP) are around 10% of gynaecology referrals.Non-relaxing pelvic floor dysfunction (NRPFD) is an under-appreciated cause for CPP with dyspareunia where no other pathology exists. The effectiveness of manual therapy in studies have shown statistically significant pre and post treatment differences.However no study has reviewed the efficacy of inclusion of trans- perineal trigger point dry needling used with manual therapy for NRPFD. This study will investigate the effectiveness of trans-perineal trigger point dry needling used with manual therapy techniques for CPP.
Study details
- Official title
- To Investigate the Use of Trans-perineal Trigger Point Dry Needling With Manual Therapy and to Compare the Outcome With Manual Therapy Treatment for Chronic Pelvic Pain With Dyspareunia. A Randomized Clinical Trial.
- Conditions
- Dyspareunia
- Interventions
- Procedure: Manual therapy
- Procedure: Trigger point dry needling
- Sponsor
- Cork University Hospital
- Collaborators
- University College Cork
- Start date
- 2016-04
- Primary completion
- 2018-04-02
- Sex
- Female
- Age range
- from 18 Years to 60 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Ireland
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients reporting non-cyclical CPP with dyspareunia and associated PFD with no palpable pelvic floor pathology, but with palpable high pelvic floor muscle (PFM) tone and tenderness will be referred for physiotherapy by the gynaecology team. * Visceral conditions like interstitial cystitis are difficult to exclude at gynaecology review, as they mimic CPP symptoms. * Smokers and non-smokers included. * Nulliparous, singleton and multiparous patients. Exclusion Criteria: * Body mass index greater than 30, makes it difficult to dry needle as the required needle length is not available. * Chronic back pain over 6 months duration, under pain management team. * Orthopaedic back surgeries with implants. * Pelvic pathologies like endometriosis, fibroids, cysts, etc. * Pregnancy related pelvic pain. * Pregnant during the trial. * Pelvic organ carcinomas. * Undergoing cancer treatment. * Post gynaecology surgeries, less than 16 weeks. * Cardiovascular, gastroenterology, renal or orthopaedic surgery, less than 6 month's post-operative. * Neurological conditions like stroke, epilepsy, Parkinson's disease etc. * Exclusion criteria for dry needling: * Extreme needle phobia, Rheumatoid arthritis, prolonged corticosteroid treatment, warfarin treatment, heart implants and blood clotting disorders. * Participant with no significant learning disability and should be able to understand the procedure to consent for treatment. * Participant should not require a chaperone during treatment.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02795026